Retail-Drug Stores and Proprietary Stores: capital spending and supply chain
SIC 5912 · 2 companies with filed cash-flow statements
Capital spending, 12 months$3.1B
Operating cash flow$18.7B
Capex / cash flow17%
Capex / revenue0.7%
Top 3 share100%
Analysis
2 companies in Retail-Drug Stores and Proprietary Stores (SIC 5912) spent $3.1B on capital projects over their latest twelve months, 17% of the $18.7B their operations generated.
Capital spending is 0.7% of the industry's $422.2B of annual revenue.
By the industry's asset mix most of it goes to equipment (37%); about $650M is imported.
The largest supplier of that spending is office and commercial structures ($626M).
Its largest supplying industries, by the input-output tables: other real estate ($64.2B), electric power generation, transmission, and distribution ($6.9B), imports ($4.5B).
Charts
Filed cash-flow statements (SEC XBRL).Capital spending × the industry’s asset mix (BEA fixed assets): grade C, an industry average applied to filed figures.BEA fixed assets: investment by asset type → supplying industry. Estimates (grade C).Purchased inputs × the industry’s input mix (BEA Use table), US part: grade C.The companies’ cash-flow statements, latest four quarters or fiscal year: every figure filed (grade A).
Evidence grades: A filed figure · B computed from filed figures · C industry average (BEA input-output and fixed-asset tables) applied to filed figures. Estimates are not the companies’ own records. Not investment advice.